Guidelines for Developing a Monitoring Plan

First Page		Document Content
Date: 2011-10-18 14:24:00 Pharmaceutical sciences Pharmaceutical industry Pharmacology Drug safety Design of experiments Data monitoring committees Clinical trial Monitoring in clinical trials Pharmacovigilance Clinical research Research Medicine		Guidelines for Developing a Monitoring Plan Add to Reading List Source URL: www.niams.nih.gov Download Document from Source Website File Size: 67,34 KB Share Document on Facebook

	Web-Scale Pharmacovigilance: Listening to Signals from the Crowd Ryen W. White Ph.D.1*, Nicholas P. Tatonetti Ph.D.2, Nigam H. Shah M.B.B.S. Ph.D.3, Russ B. Altman M.D. Ph.D.4 and Eric Horvitz M.D. Ph.D.1 1 Microsoft Re DocID: 1vpEW - View Document
	Centre Anti Poison et de Pharmacovigilance du Maroc Société Marocaine de Toxicologie DocID: 1v4Ie - View Document
	Microsoft Word - Simple guide to Veterinary Pharmacovigilance in the EU DocID: 1uY7F - View Document
	PREPARATION D’UN DIPLOME DE TOXICOLOGIE - PHARMACOVIGILANCE    DocID: 1uOXD - View Document
	Liste des inscrits à la formation de toxicologie pharmacovigilance Année 2005 – 2006 Module « Pharmacovigilance » Nom Abouali Fatima Achour Sanaa DocID: 1uKFW - View Document